IE68851B1 - Quinoxalinone derivatives - Google Patents

Quinoxalinone derivatives

Info

Publication number
IE68851B1
IE68851B1 IE287787A IE287787A IE68851B1 IE 68851 B1 IE68851 B1 IE 68851B1 IE 287787 A IE287787 A IE 287787A IE 287787 A IE287787 A IE 287787A IE 68851 B1 IE68851 B1 IE 68851B1
Authority
IE
Ireland
Prior art keywords
compound
quinoxalinone
acid
dihydro
formula
Prior art date
Application number
IE287787A
Other languages
English (en)
Other versions
IE872877L (en
Inventor
Reinhard Sarges
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of IE872877L publication Critical patent/IE872877L/xx
Publication of IE68851B1 publication Critical patent/IE68851B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
    • C07D241/50—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with hetero atoms directly attached to ring nitrogen atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cosmetics (AREA)
IE287787A 1986-10-30 1987-01-27 Quinoxalinone derivatives IE68851B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1986/002335 WO1992005160A1 (en) 1986-10-30 1986-10-30 4-arylsulfonyl-3,4-dihydro-2(1h)-quinoxalinone-1-alkanoic acids, esters, and salts

Publications (2)

Publication Number Publication Date
IE872877L IE872877L (en) 1988-04-28
IE68851B1 true IE68851B1 (en) 1996-07-24

Family

ID=22195697

Family Applications (1)

Application Number Title Priority Date Filing Date
IE287787A IE68851B1 (en) 1986-10-30 1987-01-27 Quinoxalinone derivatives

Country Status (11)

Country Link
US (1) US4940708A (enEXAMPLES)
EP (1) EP0266102B1 (enEXAMPLES)
JP (1) JPS63295566A (enEXAMPLES)
AT (1) ATE86985T1 (enEXAMPLES)
DE (1) DE3784835T2 (enEXAMPLES)
DK (1) DK561487A (enEXAMPLES)
ES (1) ES2046206T3 (enEXAMPLES)
GR (1) GR3007402T3 (enEXAMPLES)
IE (1) IE68851B1 (enEXAMPLES)
PT (1) PT85998B (enEXAMPLES)
WO (1) WO1992005160A1 (enEXAMPLES)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992005160A1 (en) * 1986-10-30 1992-04-02 Reinhard Sarges 4-arylsulfonyl-3,4-dihydro-2(1h)-quinoxalinone-1-alkanoic acids, esters, and salts
US6369057B1 (en) 1991-04-15 2002-04-09 Aventis Pharma Deutschland Gmbh Quinoxalines, processes for their preparation and their use
EP0509398B1 (de) * 1991-04-15 2001-09-19 Aventis Pharma Deutschland GmbH Chinoxaline, Verfahren zu ihrer Herstellung und ihre Verwendung
US7351709B2 (en) 2004-06-09 2008-04-01 Wyeth Estrogen receptor ligands
CA2620414A1 (en) * 2005-08-26 2007-03-01 Methylgene Inc. Benzodiazepine and benzopiperazine analog inhibitors of histone deacetylase
US8236535B2 (en) 2008-04-30 2012-08-07 Xyleco, Inc. Processing biomass
US8212087B2 (en) 2008-04-30 2012-07-03 Xyleco, Inc. Processing biomass
US7867358B2 (en) 2008-04-30 2011-01-11 Xyleco, Inc. Paper products and methods and systems for manufacturing such products
MX2010011975A (es) 2008-04-30 2011-01-21 Xyleco Inc Procesamiento de biomasa.
KR101793398B1 (ko) 2008-10-28 2017-11-02 질레코 인코포레이티드 탄화수소-함유 재료의 처리방법
WO2022109292A1 (en) * 2020-11-20 2022-05-27 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Methods and materials for inhibiting cb1 activity

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3821383A (en) * 1972-07-10 1974-06-28 Ayerst Mckenna & Harrison Compositions for and a method of treating diabetic complications
US4209527A (en) * 1979-05-16 1980-06-24 Pfizer Inc. Benzimidazolone derivatives
WO1992005160A1 (en) * 1986-10-30 1992-04-02 Reinhard Sarges 4-arylsulfonyl-3,4-dihydro-2(1h)-quinoxalinone-1-alkanoic acids, esters, and salts

Also Published As

Publication number Publication date
JPH0536436B2 (enEXAMPLES) 1993-05-31
EP0266102B1 (en) 1993-03-17
DK561487A (da) 1988-08-08
EP0266102A2 (en) 1988-05-04
WO1992005160A1 (en) 1992-04-02
JPS63295566A (ja) 1988-12-01
EP0266102A3 (en) 1989-11-23
DE3784835D1 (de) 1993-04-22
PT85998A (en) 1987-11-01
ES2046206T3 (es) 1994-02-01
DK561487D0 (da) 1987-10-27
PT85998B (pt) 1990-08-31
ATE86985T1 (de) 1993-04-15
DE3784835T2 (de) 1993-06-24
US4940708A (en) 1990-07-10
IE872877L (en) 1988-04-28
GR3007402T3 (enEXAMPLES) 1993-07-30

Similar Documents

Publication Publication Date Title
US6627611B2 (en) C-glycosides and preparation of thereof as antidiabetic agents
EP0252713B1 (en) Indolinone derivatives
BG60936B2 (bg) Нови производни на бициклични аминокиселини,методи за тяхното получаване,средства,които ги съдържат и тяхното приложение,както и нови бициклични аминокиселини като междинни продукти и методи за тяхно то получаване
HU179746B (en) Process for producing new spiro-oxasolidines
CA2016326C (en) Pyrido-pyridazinone acetic acids for treating chronic diabetic complications
EP0266102B1 (en) Quinoxalinone derivatives
US4134991A (en) Derivatives of 2-(3-phenyl-2-aminopropionyloxy)-acetic acid
JPH0660163B2 (ja) 置換オキソフタラジニル酢酸およびその同族体
EP0019440B1 (en) Benzimidazolone derivatives, process for their preparation and pharmaceutical compositions containing them
EP0269355B1 (en) Imidazolidinedione derivatives
EP0127412B1 (en) Imidazolidinedione derivatives
US5116849A (en) 4-amidino chroman and 4-amidino pyrano (3,2-c) pyridine derivatives, a process for their preparation and pharmaceutical compositions containing them
US5064852A (en) Indolinone derivatives
US4960785A (en) Indolinone derivatives
JPH04270273A (ja) チアゾリジン−２，４−ジオン誘導体とその塩及びその製造法
US4116966A (en) 1-Benzoxepino[4,3-c]pyridines
GB2050375A (en) 4-Cyanophenyl-1,4- dihydropyridine compound, processes for preparation thereof and pharmaceutical composition comprising the same
KR860001870B1 (ko) 이미다졸리딘디온 유도체의 제조방법
WO1992012979A1 (en) 2,4-DIOXO-PYRIDO [2,3-d]PYRIMIDINE-3-ACETIC ACIDS AND ESTERS AND SALTS THEREOF
JPH0583554B2 (enEXAMPLES)
PL143077B2 (en) Method of obtaining novel n2-substituted derivatives of 2h-3-acyl-4-hydroxy-5,7-dimethylpyrido-/3,2-e-1,2-thiazine 1,1 dioxide

Legal Events

Date Code Title Description
MM4A Patent lapsed